Roche increase gene therapy footprint with $1.5 billion licensing deal with Sarepta Therapeutics

On Monday, in a statement Roche said, it has entered into a $1.15 billion licensing deal with Sarepta Therapeutics to obtain the right to launch and commercialize Sarepta’s investigational gene therapy for Duchenne muscular dystrophy (DMD) outside the United States. Roche will be making an upfront payment of $750 million in cash and $400 million…

Swiss-startup SEBA Crypto AG raises $103 million in latest funding round

SEBA Crypto AG aims to be the bridge between new age financial instruments and traditional institutions. It wants to build a bank that will offer cryptocurrency services to companies and investors while at the same time extend traditional banking services to firms. In an interesting development, SEBA Crypto AG, a Swiss startup, has raised $103…

Switzerland working on regulatory framework for cryptocurrency projects

Of the 250 banks that earlier allowed companies to transact in cryptocurrencies, only two are active. While much of the business has gone to Liechtenstein, Swiss authorities are bent on taking back the crown. Regulators in Switzerland are stepping up their efforts to halt the exodus of cryptocurrency projects from the country. Currently only two…

Swiss Cryptocurrency Tezos finds itself in legal quagmire

Not only digital currencies are alike. Here is an interesting legal case involving Sweden’s Tezos cryptocurrency project where investors were left with a bad after taste. According to sources familiar with the matter at hand, Arthur and Kathleen Breitman, the couple behind the embattled cryptocurrency Tezos wants the Tezos Foundation, a Swiss-based firm, to cover…

A heady mix of cutting edge engineering and technology prowess is fueling the growth of Europe’s industrial giants

Investors are increasingly looking to reap in the benefits of cutting edge industrialization with hi-tech software prowess such as machine learning and artificial intelligence. No wonder, European Companies, including Siemens and ABB, have become a favorite among investors. Investment funds who are looking to reap rich rewards at the intersection of European efficiency and technology…